UCLA Hematology/Oncology - Pasadena

Pasadena, California 91105

2 studies enrolling now · 8 studies all time

What they study most

Breast Neoplasms, Cancer, Cancer of the Prostate, Colorectal Neoplasms, Cutaneous Melanoma, HER2 Positive Breast Cancer, Hormone Sensitive Prostate Cancer, Mesothelioma, Metastatic Breast Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC), Non-small Cell Lung Cancer, Pancreatic Neoplasms

Studies at this site

• This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. — Recruiting now
• A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 — Recruiting now
• A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors — Stopped early
• A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer — Completed
• A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2) — Completed
• Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) — Completed
• Open-Label Extension and Safety Study of Talazoparib — Completed
• A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors — Completed